Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia
- PMID: 12377750
- PMCID: PMC4027051
- DOI: 10.1161/01.atv.0000033090.81345.e6
Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia
Abstract
Objective: The adipocyte fatty acid-binding protein, aP2, has important effects on insulin resistance, lipid metabolism, and atherosclerosis. Its expression in macrophages enhances early foam cell formation and atherosclerosis in vivo. This study was designed to determine whether aP2 deficiency has a similar effect in the setting of advanced atherosclerosis and severe hypercholesterolemia.
Methods and results: Mice deficient in aP2 and apolipoprotein E (aP2(-/-)apoE(-/-) mice) and apolipoprotein E-deficient control mice (apoE(-/-) mice) were fed a Western diet for 14 weeks. No significant differences in fasting serum levels of cholesterol, triglycerides, or free fatty acids were found between groups for each sex. Compared with apoE(-/-) control mice, male and female aP2(-/-)apoE(-/-) mice had significant reductions in mean atherosclerotic lesion size in the proximal aorta, en face aorta, and innominate/right carotid artery. Feeding the Western diet in the apoE-deficient background did not cause a significant reduction in insulin sensitivity in vivo, as determined by steady-state serum glucose levels and insulin tolerance testing.
Conclusions: These data demonstrate an important role for aP2 expression in the advanced stages of atherosclerotic lesion formation. Thus, aP2 provides an important physiological link between different features of the metabolic syndrome and is a potential _target for therapy of atherosclerosis.
Figures
Similar articles
-
Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.Circulation. 2004 Sep 14;110(11):1492-8. doi: 10.1161/01.CIR.0000141735.13202.B6. Epub 2004 Sep 7. Circulation. 2004. PMID: 15353487 Free PMC article.
-
Role of macrophage-expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice.FASEB J. 2001 Dec;15(14):2733-5. doi: 10.1096/fj.01-0374fje. Epub 2001 Oct 15. FASEB J. 2001. PMID: 11606480
-
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis.Nat Med. 2001 Jun;7(6):699-705. doi: 10.1038/89076. Nat Med. 2001. PMID: 11385507 Free PMC article.
-
Macrophages, inflammation, and atherosclerosis.Int J Obes Relat Metab Disord. 2003 Dec;27 Suppl 3:S35-40. doi: 10.1038/sj.ijo.0802498. Int J Obes Relat Metab Disord. 2003. PMID: 14704742 Review.
-
Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis.Curr Opin Lipidol. 2002 Apr;13(2):141-7. doi: 10.1097/00041433-200204000-00005. Curr Opin Lipidol. 2002. PMID: 11891416 Review.
Cited by
-
Macrophage FABP4 is required for neutrophil recruitment and bacterial clearance in Pseudomonas aeruginosa pneumonia.FASEB J. 2019 Mar;33(3):3562-3574. doi: 10.1096/fj.201802002R. Epub 2018 Nov 21. FASEB J. 2019. PMID: 30462529 Free PMC article.
-
A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease.Proc Natl Acad Sci U S A. 2006 May 2;103(18):6970-5. doi: 10.1073/pnas.0602178103. Epub 2006 Apr 25. Proc Natl Acad Sci U S A. 2006. PMID: 16641093 Free PMC article.
-
Adipocyte/macrophage fatty acid binding proteins in metabolic syndrome.Curr Atheroscler Rep. 2007 Sep;9(3):222-9. doi: 10.1007/s11883-007-0023-6. Curr Atheroscler Rep. 2007. PMID: 18241617 Review.
-
Apple Supplementation Improves Hemodynamic Parameter and Attenuates Atherosclerosis in High-Fat Diet-Fed Apolipoprotein E-Knockout Mice.Biomedicines. 2020 Nov 12;8(11):495. doi: 10.3390/biomedicines8110495. Biomedicines. 2020. PMID: 33198144 Free PMC article.
-
Adipocyte Fatty Acid-Binding Protein, Cardiovascular Diseases and Mortality.Front Immunol. 2021 Mar 19;12:589206. doi: 10.3389/fimmu.2021.589206. eCollection 2021. Front Immunol. 2021. PMID: 33815359 Free PMC article. Review.
References
-
- Storch J, Thumser AE. The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta. 2000;1486:28–44. - PubMed
-
- Coe NR, Bernlohr DA. Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim Biophys Acta. 1998;1391:287–306. - PubMed
-
- Distel RJ, Robinson GS, Spiegelman BM. Fatty acid regulation of gene expression: transcriptional and post-transcriptional mechanisms. J Biol Chem. 1992;267:5937–5941. - PubMed
-
- Chaput E, Saladin R, Silvestre M, Edgar AD. Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight. Biochem Biophys Res Commun. 2000;271:445–450. - PubMed
-
- Melki SA, Abumrad NA. Expression of the adipocyte fatty acid-binding protein in streptozotocin-diabetes: effects of insulin deficiency and supplementation. J Lipid Res. 1993;34:1527–1534. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous